Review
The dual effects of interleukin-18 in tumor progression
Affiliations
- PMID: 17976312
Item in Clipboard
Review
The dual effects of interleukin-18 in tumor progression
Cell Mol Immunol.
2007 Oct.
Free article
Abstract
Interleukin-18 (IL-18) was discovered as an interferon-gamma-inducing factor and had a critical role in inflammatory and immune response. It stimulates natural killer (NK) and T cells and enhances Th1 immune response. These activated immune cells eliminate cancer cells and virus-infected cells effectively. However, IL-18 has also been found to promote tumor progression. Higher expression or secretion level of IL-18 is detected in various cancer cells in comparison with normal control, and IL-18 is able to induce angiogenesis, migration/metastasis, proliferation and immune escape. These dual effects and the mechanism of IL-18 need to be investigated further as it relates to cancer.
Similar articles
-
Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression.Cancer Metastasis Rev. 2006 Sep;25(3):417-34. doi: 10.1007/s10555-006-9013-3. Cancer Metastasis Rev. 2006. PMID: 17001512 Review.
-
[Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].Strahlenther Onkol. 2004 Apr;180(4):187-93. doi: 10.1007/s00066-004-9119-x. Strahlenther Onkol. 2004. PMID: 15057428 Review. German.
-
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.Immunol Rev. 2006 Dec;214:229-38. doi: 10.1111/j.1600-065X.2006.00445.x. Immunol Rev. 2006. PMID: 17100888 Review.
-
IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.Int Immunol. 2009 Feb;21(2):145-53. doi: 10.1093/intimm/dxn132. Epub 2008 Dec 15. Int Immunol. 2009. PMID: 19088061
-
Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells.Clin Immunol. 2008 Jun;127(3):375-84. doi: 10.1016/j.clim.2008.02.001. Epub 2008 Mar 21. Clin Immunol. 2008. PMID: 18358784
Cited by
-
Interleukins in cancer: from biology to therapy.Nat Rev Cancer. 2021 Aug;21(8):481-499. doi: 10.1038/s41568-021-00363-z. Epub 2021 Jun 3. Nat Rev Cancer. 2021. PMID: 34083781 Free PMC article. Review.
-
Antitumor strategies targeting macrophages: the importance of considering the differences in differentiation/polarization processes between human and mouse macrophages.J Immunother Cancer. 2022 Oct;10(10):e005560. doi: 10.1136/jitc-2022-005560. J Immunother Cancer. 2022. PMID: 36270732 Free PMC article. Review.
-
Interleukin-18 gene promoter and serum level in women with ovarian cancer.Mol Biol Rep. 2009 Nov;36(8):2393-7. doi: 10.1007/s11033-009-9469-7. Epub 2009 Mar 5. Mol Biol Rep. 2009. PMID: 19263242
-
Pyroptosis and inflammasomes in cancer and inflammation.MedComm (2020). 2023 Sep 24;4(5):e374. doi: 10.1002/mco2.374. eCollection 2023 Oct. MedComm (2020). 2023. PMID: 37752941 Free PMC article. Review.
-
Expression of IL-18, IL-18 binding protein, and IL-18 receptor by normal and cancerous human ovarian tissues: possible implication of IL-18 in the pathogenesis of ovarian carcinoma.Mediators Inflamm. 2014;2014:914954. doi: 10.1155/2014/914954. Epub 2014 May 15. Mediators Inflamm. 2014. PMID: 24963217 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
